Skin health
The
estrogen receptor, as well as the
progesterone receptor, have been detected in the
skin, including in
keratinocytes and
fibroblasts.
[62][63] At
menopause and thereafter, decreased levels of female
sex hormones result in
atrophy, thinning, and increased
wrinkling of the skin and a reduction in skin
elasticity, firmness, and strength.
[62][63] These skin changes constitute an acceleration in
skin aging and are the result of decreased
collagen content, irregularities in the
morphology of
epidermal skin cells, decreased
ground substance between
skin fibers, and reduced
capillaries and
blood flow.
[62][63] The skin also becomes more
dry during menopause, which is due to reduced skin
hydration and
surface lipids (sebum production).
[62] Along with chronological aging and photoaging, estrogen deficiency in menopause is one of the three main factors that predominantly influences skin aging.
[62]
Hormone replacement therapy, consisting of systemic treatment with estrogen alone or in combination with a progestogen, has well-documented and considerable beneficial effects on the skin of postmenopausal women.
[62][63] These benefits include increased skin collagen content, skin thickness and elasticity, and skin hydration and surface lipids.
[62][63] Topical estrogen has been found to have similar beneficial effects on the skin.
[62] In addition, a study has found that topical 2% progesterone cream significantly increases skin elasticity and firmness and observably decreases wrinkles in peri- and postmenopausal women.
[63] Skin hydration and surface lipids, on the other hand, did not significantly change with topical progesterone.
[63] These findings suggest that progesterone, like estrogen, also has beneficial effects on the skin, and may be independently protective against skin aging.
[63]